Market Overview

Endo Higher After Q3 Beat

Related ENDP
Akorn Upgraded By Piper Jaffray On Improved Cost Structure, Product Potential
The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise
Biotech Stocks Bloodied But Can Now Drive M&A (Seeking Alpha)

Endo International plc - Ordinary Shares (NASDAQ: ENDP) shares are trading higher by 54 cents (8.8 percent) at $6.63 in Friday's session.

The catalyst for the rally is a Q3 EPS beat of 24 cents along with a sales beat of $2.88 million.

After a higher open, Endo had a brief retreat but found support just below Thursday's close ($6.09), reaching $6.03 before continuing its move higher. The ensuing rally took the stock to $7.00, but has backed off that high. That marks the first it has traded in the $7.00 handle since October 26, when it peaked at $7.30.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (ENDP)

View Comments and Join the Discussion!

Instagram Stories: Anything Snap Can Do, We Can Do Better

China Recycling Energy Surges On Trump Speculation